Piermont Valley Acquisition（CMCA.F）株式概要Capitalworks Emerging Markets Acquisition Corp.は重要な業務を行っていない。 詳細CMCA.F ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析マイナスの株主資本 負債は営業キャッシュフローで十分にカバーされていない 過去5年間で収益は年間82.1%減少しました。 収益が 100 万ドル未満 ( $0 )+2 さらなるリスクすべてのリスクチェックを見るCMCA.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$2.60該当なし内在価値ディスカウントEst. Revenue$PastFuture-373k13m2016201920222025202620282031Revenue US$1.0Earnings US$0.3AdvancedSet Fair ValueView all narrativesPiermont Valley Acquisition Corp 競合他社Baker Global Asset ManagementSymbol: OTCPK:BAKRMarket cap: US$13.7mEquus Total ReturnSymbol: NYSE:EQSMarket cap: US$18.4mAlpha G Investment ManagementSymbol: OTCPK:TETA.AMarket cap: US$20.4mHorizon Group PropertiesSymbol: OTCPK:HGPIMarket cap: US$22.4m価格と性能株価の高値、安値、推移の概要Piermont Valley Acquisition過去の株価現在の株価US$2.6052週高値US$2.6052週安値US$2.60ベータ-0.651ヶ月の変化0%3ヶ月変化n/a1年変化n/a3年間の変化-75.21%5年間の変化n/aIPOからの変化n/a最新ニュースお知らせ • Apr 21Tigerless Health, Inc. entered into a definitive business combination agreement to acquire Piermont Valley Acquisition Corp (OTCPK:CMCA.F) in a reverse merger transaction for an enterprise value of approximately $280 million.Tigerless Health, Inc. entered into a definitive business combination agreement to acquire Piermont Valley Acquisition Corp (OTCPK:CMCA.F) in a reverse merger transaction for an enterprise value of approximately $280 million on April 17, 2026. The consideration consists of common equity of Piermont Valley Acquisition Corp to be issued for common equity of Tigerless Health, Inc. The consideration also includes an earnout/contingent payment. The combined company is expected to be renamed “Tigerless AI Holdings, Inc.” and trade on NASDAQ allowing Tigerless Health to continue building its proprietary artificial intelligence (AI) capabilities designed to improve how users access and navigate insurance. Accordingly, upon consummation of the Acquisition Merger and Reorganization Merger, the former stockholders of Tigerless will hold an aggregate of 5,600,000 shares of Tigerless AI Holdings, Inc Class A common stock and 22,400,000 shares of Tigerless AI Holdings, Inc Class B common stock and the former stockholders of Piermont will hold an aggregate of 5,952,886 shares of Tigerless AI Holdings, Inc Class A common stock. Existing Tigerless Health shareholders will roll 100% of their equity into the combined company upon closing of the transaction. Tigerless Health, Inc.'s management team, led by founder and CEO Zikang Wu, will continue to lead the combined company following the close of the transaction. The transaction is subject to required regulatory approvals, approval by the stockholders of Tigerless Health, Inc. and Piermont Valley Acquisition Corp, and the satisfaction or waiver of other customary closing conditions. The deal has been unanimously approved by the board of directors of Tigerless Health, Inc. and Piermont Valley Acquisition Corp. The transaction is expected to close in the second half of 2026. Ari Edelman of Edelman Legal Advisory PLLC acted as legal advisor to Piermont Valley Acquisition Corp. Jeffrey M. Gallant and Brian L. Ross of Graubard Miller acted as legal advisor to Tigerless Health, Inc. Continental Stock Transfer & Trust Company acted as information agent to Piermont Valley Acquisition Corp.お知らせ • Sep 06The Nasdaq Stock Market to Delist Ordinary Shares of Capitalworks Emerging Markets AcquisitionThe Nasdaq Stock Market announced that it will delist the ordinary shares, units, and warrants of Capitalworks Emerging Markets Acquisition Corp. The company’s Securities were suspended on June 12, 2024, and have not traded on Nasdaq since that time.お知らせ • Aug 15Capitalworks Emerging Markets Acquisition Corp announced delayed 10-Q filingOn 08/14/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 03Capitalworks Emerging Markets Acquisition Corp announced delayed annual 10-K filingOn 07/02/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jun 13Capitalworks Emerging Markets Acquisition Corp(NasdaqGM:CMCA) dropped from NASDAQ Composite IndexCapitalworks Emerging Markets Acquisition Corp has been dropped from NASDAQ Composite Index .お知らせ • Apr 26Capitalworks Emerging Markets Acquisition Receives Notice from Nasdaq Indicates it Did Not Regain Compliance with the Minimum Total Holders Rule During the Extension PeriodAs previously reported, on September 7, 2023, Capitalworks Emerging Markets Acquisition Corp. (the ‘Company’) received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (the ‘Nasdaq’) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market (the ‘Minimum Total Holders Rule’). Pursuant to Nasdaq Listing Rule 5810(c)(2)(B)(i), the maximum amount of time for the Company to regain compliance with the Minimum Total Holders Rule is 180 days, or until March 5, 2024 (the ‘Extension Period’). On March 15, 2024, the Company submitted an application to transfer its securities to the Nasdaq Capital Market and paid $5,000 application fee. Nasdaq indicated that the Company does not currently meet the 300 public holder requirement for continued listing on the Nasdaq Capital Market. On April 18, 2024, the Company received a notice (the ‘Notice’) from Nasdaq indicating that the Company did not regain compliance with the Minimum Total Holders Rule during the Extension Period. Pursuant to the Notice, unless the Company requests a hearing before the Nasdaq Hearings Panel (the ‘Panel’) by April 25, 2024, the Company’s securities would be subject to suspension and delisting from the Nasdaq Global Market at the opening of business on April 29, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq. The Company intends to timely request a hearing before the Panel to appeal the Notice. The hearing request will stay the suspension of trading on the Company’s securities, and the Company’s securities will continue to trade on the Nasdaq Global Market until the hearing process concludes and the Panel issues a written decision. There can be no assurance that the hearing before the Panel will be successful.最新情報をもっと見るRecent updatesお知らせ • Apr 21Tigerless Health, Inc. entered into a definitive business combination agreement to acquire Piermont Valley Acquisition Corp (OTCPK:CMCA.F) in a reverse merger transaction for an enterprise value of approximately $280 million.Tigerless Health, Inc. entered into a definitive business combination agreement to acquire Piermont Valley Acquisition Corp (OTCPK:CMCA.F) in a reverse merger transaction for an enterprise value of approximately $280 million on April 17, 2026. The consideration consists of common equity of Piermont Valley Acquisition Corp to be issued for common equity of Tigerless Health, Inc. The consideration also includes an earnout/contingent payment. The combined company is expected to be renamed “Tigerless AI Holdings, Inc.” and trade on NASDAQ allowing Tigerless Health to continue building its proprietary artificial intelligence (AI) capabilities designed to improve how users access and navigate insurance. Accordingly, upon consummation of the Acquisition Merger and Reorganization Merger, the former stockholders of Tigerless will hold an aggregate of 5,600,000 shares of Tigerless AI Holdings, Inc Class A common stock and 22,400,000 shares of Tigerless AI Holdings, Inc Class B common stock and the former stockholders of Piermont will hold an aggregate of 5,952,886 shares of Tigerless AI Holdings, Inc Class A common stock. Existing Tigerless Health shareholders will roll 100% of their equity into the combined company upon closing of the transaction. Tigerless Health, Inc.'s management team, led by founder and CEO Zikang Wu, will continue to lead the combined company following the close of the transaction. The transaction is subject to required regulatory approvals, approval by the stockholders of Tigerless Health, Inc. and Piermont Valley Acquisition Corp, and the satisfaction or waiver of other customary closing conditions. The deal has been unanimously approved by the board of directors of Tigerless Health, Inc. and Piermont Valley Acquisition Corp. The transaction is expected to close in the second half of 2026. Ari Edelman of Edelman Legal Advisory PLLC acted as legal advisor to Piermont Valley Acquisition Corp. Jeffrey M. Gallant and Brian L. Ross of Graubard Miller acted as legal advisor to Tigerless Health, Inc. Continental Stock Transfer & Trust Company acted as information agent to Piermont Valley Acquisition Corp.お知らせ • Sep 06The Nasdaq Stock Market to Delist Ordinary Shares of Capitalworks Emerging Markets AcquisitionThe Nasdaq Stock Market announced that it will delist the ordinary shares, units, and warrants of Capitalworks Emerging Markets Acquisition Corp. The company’s Securities were suspended on June 12, 2024, and have not traded on Nasdaq since that time.お知らせ • Aug 15Capitalworks Emerging Markets Acquisition Corp announced delayed 10-Q filingOn 08/14/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 03Capitalworks Emerging Markets Acquisition Corp announced delayed annual 10-K filingOn 07/02/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jun 13Capitalworks Emerging Markets Acquisition Corp(NasdaqGM:CMCA) dropped from NASDAQ Composite IndexCapitalworks Emerging Markets Acquisition Corp has been dropped from NASDAQ Composite Index .お知らせ • Apr 26Capitalworks Emerging Markets Acquisition Receives Notice from Nasdaq Indicates it Did Not Regain Compliance with the Minimum Total Holders Rule During the Extension PeriodAs previously reported, on September 7, 2023, Capitalworks Emerging Markets Acquisition Corp. (the ‘Company’) received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (the ‘Nasdaq’) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market (the ‘Minimum Total Holders Rule’). Pursuant to Nasdaq Listing Rule 5810(c)(2)(B)(i), the maximum amount of time for the Company to regain compliance with the Minimum Total Holders Rule is 180 days, or until March 5, 2024 (the ‘Extension Period’). On March 15, 2024, the Company submitted an application to transfer its securities to the Nasdaq Capital Market and paid $5,000 application fee. Nasdaq indicated that the Company does not currently meet the 300 public holder requirement for continued listing on the Nasdaq Capital Market. On April 18, 2024, the Company received a notice (the ‘Notice’) from Nasdaq indicating that the Company did not regain compliance with the Minimum Total Holders Rule during the Extension Period. Pursuant to the Notice, unless the Company requests a hearing before the Nasdaq Hearings Panel (the ‘Panel’) by April 25, 2024, the Company’s securities would be subject to suspension and delisting from the Nasdaq Global Market at the opening of business on April 29, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq. The Company intends to timely request a hearing before the Panel to appeal the Notice. The hearing request will stay the suspension of trading on the Company’s securities, and the Company’s securities will continue to trade on the Nasdaq Global Market until the hearing process concludes and the Panel issues a written decision. There can be no assurance that the hearing before the Panel will be successful.お知らせ • Feb 16Capitalworks Emerging Markets Acquisition Corp announced delayed 10-Q filingOn 02/15/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 17Capitalworks Emerging Markets Acquisition Corp announced delayed 10-Q filingOn 11/15/2023, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Sep 13Capitalworks Emerging Markets Acquisition Receives a Written Notice from the Listing Qualifications Department of the Nasdaq Stock MarketOn September 7, 2023, Capitalworks Emerging Markets Acquisition Corp. received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market notifying the Company that the Company was not in compliance with Listing Rule 5450(a)(2), which requires the Company to have at least 400 shareholders for continued listing on the Nasdaq Global Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq Global Market. The Notice states that the Company has 45 calendar days to submit a plan to regain compliance with the Minimum Total Holders Rule. The Company intends to submit a plan to regain compliance with the Minimum Total Holders Rule within the required timeframe. If Nasdaq accepts the Company’s plan, Nasdaq may grant the Company an extension of up to 180 calendar days from the date of the Notice to evidence compliance with the Minimum Total Holders Rule. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel.お知らせ • Jun 30Capitalworks Emerging Markets Acquisition Corp announced delayed annual 10-K filingOn 06/29/2023, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jul 01Capitalworks Emerging Markets Acquisition Corp announced delayed annual 10-K filingOn 06/30/2022, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.株主還元CMCA.FUS Capital MarketsUS 市場7D0%0.7%-4.1%1Yn/a7.6%20.6%株主還元を見る業界別リターン: CMCA.FがUS Capital Markets業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: CMCA.F US市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is CMCA.F's price volatile compared to industry and market?CMCA.F volatilityCMCA.F Average Weekly Movementn/aCapital Markets Industry Average Movement3.6%Market Average Movement7.2%10% most volatile stocks in US Market16.6%10% least volatile stocks in US Market3.1%安定した株価: CMCA.Fの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のCMCA.Fのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト2021n/aWayne Qianwww.cemac.onlineキャピタルワークス・エマージング・マーケッツ・アクイジション・コーポレーションは、重要な業務を行っていない。同社は、1つまたは複数の企業との合併、資本交換、資産買収、株式購入、組織再編、または同様の企業結合を行うことに重点を置いている。消費財・消費者テクノロジー、金融・ビジネスサービス、ヘルスケア・テクノロジー、メディア・通信の各分野で事業を展開する企業を対象としている。同社は2021年に設立され、ニューヨーク州ニューヨークに本社を置いている。Capitalworks Emerging Markets Acquisition CorpはCEMAC Sponsor LPの子会社である。もっと見るPiermont Valley Acquisition Corp 基礎のまとめPiermont Valley Acquisition の収益と売上を時価総額と比較するとどうか。CMCA.F 基礎統計学時価総額US$15.48m収益（TTM）-US$372.89k売上高(TTM)n/a0.0xP/Sレシオ-41.5xPER（株価収益率CMCA.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計CMCA.F 損益計算書（TTM）収益US$0売上原価US$0売上総利益US$0その他の費用US$372.89k収益-US$372.89k直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.063グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率-17.1%CMCA.F の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/11 16:43終値2026/04/28 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Piermont Valley Acquisition Corp 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 21Tigerless Health, Inc. entered into a definitive business combination agreement to acquire Piermont Valley Acquisition Corp (OTCPK:CMCA.F) in a reverse merger transaction for an enterprise value of approximately $280 million.Tigerless Health, Inc. entered into a definitive business combination agreement to acquire Piermont Valley Acquisition Corp (OTCPK:CMCA.F) in a reverse merger transaction for an enterprise value of approximately $280 million on April 17, 2026. The consideration consists of common equity of Piermont Valley Acquisition Corp to be issued for common equity of Tigerless Health, Inc. The consideration also includes an earnout/contingent payment. The combined company is expected to be renamed “Tigerless AI Holdings, Inc.” and trade on NASDAQ allowing Tigerless Health to continue building its proprietary artificial intelligence (AI) capabilities designed to improve how users access and navigate insurance. Accordingly, upon consummation of the Acquisition Merger and Reorganization Merger, the former stockholders of Tigerless will hold an aggregate of 5,600,000 shares of Tigerless AI Holdings, Inc Class A common stock and 22,400,000 shares of Tigerless AI Holdings, Inc Class B common stock and the former stockholders of Piermont will hold an aggregate of 5,952,886 shares of Tigerless AI Holdings, Inc Class A common stock. Existing Tigerless Health shareholders will roll 100% of their equity into the combined company upon closing of the transaction. Tigerless Health, Inc.'s management team, led by founder and CEO Zikang Wu, will continue to lead the combined company following the close of the transaction. The transaction is subject to required regulatory approvals, approval by the stockholders of Tigerless Health, Inc. and Piermont Valley Acquisition Corp, and the satisfaction or waiver of other customary closing conditions. The deal has been unanimously approved by the board of directors of Tigerless Health, Inc. and Piermont Valley Acquisition Corp. The transaction is expected to close in the second half of 2026. Ari Edelman of Edelman Legal Advisory PLLC acted as legal advisor to Piermont Valley Acquisition Corp. Jeffrey M. Gallant and Brian L. Ross of Graubard Miller acted as legal advisor to Tigerless Health, Inc. Continental Stock Transfer & Trust Company acted as information agent to Piermont Valley Acquisition Corp.
お知らせ • Sep 06The Nasdaq Stock Market to Delist Ordinary Shares of Capitalworks Emerging Markets AcquisitionThe Nasdaq Stock Market announced that it will delist the ordinary shares, units, and warrants of Capitalworks Emerging Markets Acquisition Corp. The company’s Securities were suspended on June 12, 2024, and have not traded on Nasdaq since that time.
お知らせ • Aug 15Capitalworks Emerging Markets Acquisition Corp announced delayed 10-Q filingOn 08/14/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 03Capitalworks Emerging Markets Acquisition Corp announced delayed annual 10-K filingOn 07/02/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jun 13Capitalworks Emerging Markets Acquisition Corp(NasdaqGM:CMCA) dropped from NASDAQ Composite IndexCapitalworks Emerging Markets Acquisition Corp has been dropped from NASDAQ Composite Index .
お知らせ • Apr 26Capitalworks Emerging Markets Acquisition Receives Notice from Nasdaq Indicates it Did Not Regain Compliance with the Minimum Total Holders Rule During the Extension PeriodAs previously reported, on September 7, 2023, Capitalworks Emerging Markets Acquisition Corp. (the ‘Company’) received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (the ‘Nasdaq’) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market (the ‘Minimum Total Holders Rule’). Pursuant to Nasdaq Listing Rule 5810(c)(2)(B)(i), the maximum amount of time for the Company to regain compliance with the Minimum Total Holders Rule is 180 days, or until March 5, 2024 (the ‘Extension Period’). On March 15, 2024, the Company submitted an application to transfer its securities to the Nasdaq Capital Market and paid $5,000 application fee. Nasdaq indicated that the Company does not currently meet the 300 public holder requirement for continued listing on the Nasdaq Capital Market. On April 18, 2024, the Company received a notice (the ‘Notice’) from Nasdaq indicating that the Company did not regain compliance with the Minimum Total Holders Rule during the Extension Period. Pursuant to the Notice, unless the Company requests a hearing before the Nasdaq Hearings Panel (the ‘Panel’) by April 25, 2024, the Company’s securities would be subject to suspension and delisting from the Nasdaq Global Market at the opening of business on April 29, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq. The Company intends to timely request a hearing before the Panel to appeal the Notice. The hearing request will stay the suspension of trading on the Company’s securities, and the Company’s securities will continue to trade on the Nasdaq Global Market until the hearing process concludes and the Panel issues a written decision. There can be no assurance that the hearing before the Panel will be successful.
お知らせ • Apr 21Tigerless Health, Inc. entered into a definitive business combination agreement to acquire Piermont Valley Acquisition Corp (OTCPK:CMCA.F) in a reverse merger transaction for an enterprise value of approximately $280 million.Tigerless Health, Inc. entered into a definitive business combination agreement to acquire Piermont Valley Acquisition Corp (OTCPK:CMCA.F) in a reverse merger transaction for an enterprise value of approximately $280 million on April 17, 2026. The consideration consists of common equity of Piermont Valley Acquisition Corp to be issued for common equity of Tigerless Health, Inc. The consideration also includes an earnout/contingent payment. The combined company is expected to be renamed “Tigerless AI Holdings, Inc.” and trade on NASDAQ allowing Tigerless Health to continue building its proprietary artificial intelligence (AI) capabilities designed to improve how users access and navigate insurance. Accordingly, upon consummation of the Acquisition Merger and Reorganization Merger, the former stockholders of Tigerless will hold an aggregate of 5,600,000 shares of Tigerless AI Holdings, Inc Class A common stock and 22,400,000 shares of Tigerless AI Holdings, Inc Class B common stock and the former stockholders of Piermont will hold an aggregate of 5,952,886 shares of Tigerless AI Holdings, Inc Class A common stock. Existing Tigerless Health shareholders will roll 100% of their equity into the combined company upon closing of the transaction. Tigerless Health, Inc.'s management team, led by founder and CEO Zikang Wu, will continue to lead the combined company following the close of the transaction. The transaction is subject to required regulatory approvals, approval by the stockholders of Tigerless Health, Inc. and Piermont Valley Acquisition Corp, and the satisfaction or waiver of other customary closing conditions. The deal has been unanimously approved by the board of directors of Tigerless Health, Inc. and Piermont Valley Acquisition Corp. The transaction is expected to close in the second half of 2026. Ari Edelman of Edelman Legal Advisory PLLC acted as legal advisor to Piermont Valley Acquisition Corp. Jeffrey M. Gallant and Brian L. Ross of Graubard Miller acted as legal advisor to Tigerless Health, Inc. Continental Stock Transfer & Trust Company acted as information agent to Piermont Valley Acquisition Corp.
お知らせ • Sep 06The Nasdaq Stock Market to Delist Ordinary Shares of Capitalworks Emerging Markets AcquisitionThe Nasdaq Stock Market announced that it will delist the ordinary shares, units, and warrants of Capitalworks Emerging Markets Acquisition Corp. The company’s Securities were suspended on June 12, 2024, and have not traded on Nasdaq since that time.
お知らせ • Aug 15Capitalworks Emerging Markets Acquisition Corp announced delayed 10-Q filingOn 08/14/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 03Capitalworks Emerging Markets Acquisition Corp announced delayed annual 10-K filingOn 07/02/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jun 13Capitalworks Emerging Markets Acquisition Corp(NasdaqGM:CMCA) dropped from NASDAQ Composite IndexCapitalworks Emerging Markets Acquisition Corp has been dropped from NASDAQ Composite Index .
お知らせ • Apr 26Capitalworks Emerging Markets Acquisition Receives Notice from Nasdaq Indicates it Did Not Regain Compliance with the Minimum Total Holders Rule During the Extension PeriodAs previously reported, on September 7, 2023, Capitalworks Emerging Markets Acquisition Corp. (the ‘Company’) received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (the ‘Nasdaq’) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market (the ‘Minimum Total Holders Rule’). Pursuant to Nasdaq Listing Rule 5810(c)(2)(B)(i), the maximum amount of time for the Company to regain compliance with the Minimum Total Holders Rule is 180 days, or until March 5, 2024 (the ‘Extension Period’). On March 15, 2024, the Company submitted an application to transfer its securities to the Nasdaq Capital Market and paid $5,000 application fee. Nasdaq indicated that the Company does not currently meet the 300 public holder requirement for continued listing on the Nasdaq Capital Market. On April 18, 2024, the Company received a notice (the ‘Notice’) from Nasdaq indicating that the Company did not regain compliance with the Minimum Total Holders Rule during the Extension Period. Pursuant to the Notice, unless the Company requests a hearing before the Nasdaq Hearings Panel (the ‘Panel’) by April 25, 2024, the Company’s securities would be subject to suspension and delisting from the Nasdaq Global Market at the opening of business on April 29, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq. The Company intends to timely request a hearing before the Panel to appeal the Notice. The hearing request will stay the suspension of trading on the Company’s securities, and the Company’s securities will continue to trade on the Nasdaq Global Market until the hearing process concludes and the Panel issues a written decision. There can be no assurance that the hearing before the Panel will be successful.
お知らせ • Feb 16Capitalworks Emerging Markets Acquisition Corp announced delayed 10-Q filingOn 02/15/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 17Capitalworks Emerging Markets Acquisition Corp announced delayed 10-Q filingOn 11/15/2023, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Sep 13Capitalworks Emerging Markets Acquisition Receives a Written Notice from the Listing Qualifications Department of the Nasdaq Stock MarketOn September 7, 2023, Capitalworks Emerging Markets Acquisition Corp. received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market notifying the Company that the Company was not in compliance with Listing Rule 5450(a)(2), which requires the Company to have at least 400 shareholders for continued listing on the Nasdaq Global Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq Global Market. The Notice states that the Company has 45 calendar days to submit a plan to regain compliance with the Minimum Total Holders Rule. The Company intends to submit a plan to regain compliance with the Minimum Total Holders Rule within the required timeframe. If Nasdaq accepts the Company’s plan, Nasdaq may grant the Company an extension of up to 180 calendar days from the date of the Notice to evidence compliance with the Minimum Total Holders Rule. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel.
お知らせ • Jun 30Capitalworks Emerging Markets Acquisition Corp announced delayed annual 10-K filingOn 06/29/2023, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jul 01Capitalworks Emerging Markets Acquisition Corp announced delayed annual 10-K filingOn 06/30/2022, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.
